Further research revealed that miR-124, which is significantly downregulated in breast cancer bone metastases, inhibits osteoclastogenesis and suppresses bone metastasis through direct targeting of its downstream gene, IL-11 (Cai et al., 2018). This evidence concerns the gene IL11 and breast cancer.